Nuveen’s ImmunityBio IBRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.75M Buy
879,571
+246,477
+39% +$1.69M ﹤0.01% 1760
2025
Q4
$1.25M Buy
633,094
+125,134
+25% +$284K ﹤0.01% 2503
2025
Q3
$1.25M Buy
507,960
+76,860
+18% +$198K ﹤0.01% 2518
2025
Q2
$1.14M Buy
431,100
+71,431
+20% +$192K ﹤0.01% 2546
2025
Q1
$1.08M Buy
359,669
+4,367
+1% +$13.2K ﹤0.01% 2612
2024
Q4
$910K Sell
355,302
-48,226
-12% -$201K ﹤0.01% 2753
2024
Q3
$1.5M Hold
403,528
﹤0.01% 2564
2024
Q2
$2.55M Sell
403,528
-102,897
-20% -$678K ﹤0.01% 2264
2024
Q1
$2.72M Sell
506,425
-16,052
-3% -$72.7K ﹤0.01% 2259
2023
Q4
$2.62M Buy
522,477
+45,198
+9% +$142K ﹤0.01% 2289
2023
Q3
$807K Buy
477,279
+47,554
+11% +$95.5K ﹤0.01% 2658
2023
Q2
$1.19M Buy
429,725
+189,140
+79% +$535K ﹤0.01% 2585
2023
Q1
$438K Sell
240,585
-8,313
-3% -$25.8K ﹤0.01% 2839
2022
Q4
$3.83M Sell
248,898
-21,085
-8% -$116K ﹤0.01% 2069
2022
Q3
$1.34M Sell
269,983
-3,855
-1% -$17.6K ﹤0.01% 2601
2022
Q2
$1.02M Sell
273,838
-4,882
-2% -$19.6K ﹤0.01% 2770
2022
Q1
$1.56M Sell
278,720
-169,558
-38% -$1.04M ﹤0.01% 2626
2021
Q4
$2.73M Buy
448,278
+181,842
+68% +$1.37M ﹤0.01% 2408
2021
Q3
$2.6M Sell
266,436
-311,464
-54% -$3.43M ﹤0.01% 2548
2021
Q2
$1.73M Buy
+577,900
New +$9.55M ﹤0.01% 2781
2021
Q1
Sell
-112,537
Closed -$1.5M 3385
2020
Q4
$1.5M Sell
112,537
-731
-0.6% -$7.03K ﹤0.01% 2645
2020
Q3
$785K Buy
113,268
+472
+0.4% +$4.71K ﹤0.01% 2791
2020
Q2
$1.39M Buy
+112,796
New +$637K ﹤0.01% 2483

Other funds holding IBRX